Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 59% ± 15% | |
lung | 19 studies | 49% ± 17% | |
intestine | 11 studies | 42% ± 17% | |
brain | 11 studies | 34% ± 11% | |
eye | 10 studies | 40% ± 19% | |
kidney | 9 studies | 44% ± 17% | |
lymph node | 6 studies | 56% ± 19% | |
bone marrow | 6 studies | 34% ± 16% | |
liver | 6 studies | 41% ± 18% | |
pancreas | 5 studies | 56% ± 22% | |
uterus | 5 studies | 58% ± 11% | |
placenta | 4 studies | 45% ± 13% | |
heart | 4 studies | 25% ± 5% | |
adipose | 4 studies | 28% ± 16% | |
prostate | 4 studies | 48% ± 10% | |
breast | 4 studies | 56% ± 6% | |
adrenal gland | 3 studies | 50% ± 9% | |
esophagus | 3 studies | 54% ± 27% | |
skin | 3 studies | 49% ± 17% | |
thymus | 3 studies | 66% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 21217.40 | 459 / 459 | 100% | 336.35 | 1118 / 1118 |
esophagus | 100% | 18192.66 | 1445 / 1445 | 100% | 295.91 | 183 / 183 |
intestine | 100% | 19093.32 | 966 / 966 | 100% | 279.05 | 527 / 527 |
liver | 100% | 11896.10 | 226 / 226 | 100% | 185.91 | 406 / 406 |
ovary | 100% | 23744.92 | 180 / 180 | 100% | 309.19 | 430 / 430 |
pancreas | 100% | 12584.72 | 328 / 328 | 100% | 257.39 | 178 / 178 |
prostate | 100% | 18278.31 | 245 / 245 | 100% | 411.46 | 502 / 502 |
stomach | 100% | 15433.79 | 359 / 359 | 100% | 248.66 | 286 / 286 |
thymus | 100% | 16502.14 | 653 / 653 | 100% | 358.70 | 605 / 605 |
uterus | 100% | 22568.33 | 170 / 170 | 100% | 367.56 | 459 / 459 |
lung | 100% | 19423.15 | 577 / 578 | 100% | 356.47 | 1155 / 1155 |
bladder | 100% | 23504.71 | 21 / 21 | 100% | 292.96 | 503 / 504 |
kidney | 100% | 13929.09 | 89 / 89 | 100% | 239.88 | 897 / 901 |
skin | 100% | 19625.45 | 1808 / 1809 | 100% | 301.35 | 470 / 472 |
brain | 99% | 11866.79 | 2624 / 2642 | 100% | 324.71 | 705 / 705 |
adrenal gland | 100% | 20040.25 | 258 / 258 | 99% | 245.27 | 228 / 230 |
adipose | 100% | 21290.48 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 23961.86 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 316.64 | 29 / 29 |
muscle | 100% | 49273.52 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 13270.73 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 417.55 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 113.56 | 1 / 1 |
heart | 98% | 18693.05 | 845 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 14060.32 | 897 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 166.31 | 77 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_2000767 | Biological process | positive regulation of cytoplasmic translation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0071919 | Biological process | G-quadruplex DNA formation |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003727 | Molecular function | single-stranded RNA binding |
GO_0045182 | Molecular function | translation regulator activity |
GO_0003729 | Molecular function | mRNA binding |
GO_0051880 | Molecular function | G-quadruplex DNA binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CNBP |
Protein name | CCHC-type zinc finger nucleic acid binding protein isoform 2 CCHC-type zinc finger nucleic acid binding protein (Cellular nucleic acid-binding protein) (CNBP) (Zinc finger protein 9) CCHC-type zinc finger nucleic acid binding protein (Cellular nucleic acid-binding protein) (Zinc finger protein 9) CCHC-type zinc finger nucleic acid binding protein |
Synonyms | ZNF9 RNF163 |
Description | FUNCTION: Single-stranded DNA-binding protein that preferentially binds to the sterol regulatory element (SRE) sequence 5'-GTGCGGTG-3', and thereby mediates transcriptional repression . Has a role as transactivator of the Myc promoter (By similarity). Binds single-stranded RNA in a sequence-specific manner (By similarity). .; FUNCTION: [Isoform 1]: Binds G-rich elements in target mRNA coding sequences . Prevents G-quadruplex structure formation in vitro, suggesting a role in supporting translation by resolving stable structures on mRNAs . .; FUNCTION: [Isoform 2]: Binds to RNA. .; FUNCTION: [Isoform 4]: Binds to RNA. .; FUNCTION: [Isoform 5]: Binds to RNA. .; FUNCTION: [Isoform 6]: Binds to RNA. .; FUNCTION: [Isoform 8]: Binds to RNA. . |
Accessions | ENST00000441626.6 [P62633-6] ENST00000504813.5 [P62633-3] P62633 ENST00000422453.7 [P62633-1] ENST00000451728.6 [P62633-4] D6RAT4 ENST00000512338.1 A0A0S2Z4Q3 ENST00000446936.6 [P62633-5] A0A0S2Z4K2 A0A0S2Z4P7 ENST00000500450.6 [P62633-7] ENST00000502976.5 [P62633-2] |